Drugs Made In America Acquisition Corp
DMAA10.440USD
-0.010-0.10%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
349.92MMarket Cap
95.17P/E TTM
More Details of Drugs Made In America Acquisition Corp Company
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp Info
Ticker SymbolDMAA
Company nameDrugs Made In America Acquisition Corp
IPO dateJan 28, 2025
CEOStockwell (Lynn)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJan 28
Address1 East Broward Boulevard
CityFT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone19548703099
Website
Ticker SymbolDMAA
IPO dateJan 28, 2025
CEOStockwell (Lynn)
Company Executives of Drugs Made In America Acquisition Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
Other
49.03%
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
Other
49.03%
Shareholder Types
Shareholders
Proportion
Hedge Fund
30.42%
Corporation
25.57%
Investment Advisor/Hedge Fund
24.61%
Investment Advisor
5.80%
Research Firm
5.62%
Individual Investor
1.19%
Other
6.79%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
47
22.21M
67.76%
-8.45K
2025Q3
47
22.22M
67.76%
+1.02M
2025Q2
38
21.21M
54.90%
+2.81M
2025Q1
25
18.33M
0.00%
+18.33M
2024Q4
5
4.59M
15.73%
+4.59M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Drugs Made In America Acquisition LLC
8.57M
25.57%
+4.38M
+104.63%
Feb 25, 2025
Karpus Investment Management
2.55M
7.6%
-196.44K
-7.16%
Sep 30, 2025
First Trust Capital Management L.P.
2.24M
6.69%
--
--
Sep 30, 2025
Polar Asset Management Partners Inc.
1.90M
5.67%
--
--
Sep 30, 2025
Glazer Capital, LLC
1.82M
5.44%
-158.00
-0.01%
Sep 30, 2025
Westchester Capital Management, LLC
1.67M
4.98%
--
--
Sep 30, 2025
Hudson Bay Capital Management LP
1.55M
4.62%
-250.00K
-13.89%
Sep 30, 2025
Wolverine Asset Management, LLC
1.25M
3.73%
+227.22K
+22.24%
Sep 30, 2025
Mizuho Securities USA, LLC.
1.10M
3.28%
+180.66K
+19.64%
Sep 30, 2025
Aristeia Capital, L.L.C.
881.72K
2.63%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
